These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36838925)

  • 21. Carbohydrate-based cancer vaccines: target cancer with sugar bullets.
    Liu CC; Ye XS
    Glycoconj J; 2012 Aug; 29(5-6):259-71. PubMed ID: 22669462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity study of Globo H analogues with modification at the reducing or nonreducing end of the tumor antigen.
    Lee HY; Chen CY; Tsai TI; Li ST; Lin KH; Cheng YY; Ren CT; Cheng TJ; Wu CY; Wong CH
    J Am Chem Soc; 2014 Dec; 136(48):16844-53. PubMed ID: 25371992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor cell-based vaccine: an effective strategy for eradication of cancer cells.
    Sadeghi Najafabadi SA; Bolhassani A; Aghasadeghi MR
    Immunotherapy; 2022 Jun; 14(8):639-654. PubMed ID: 35481358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ganglioside GM3-based anticancer vaccines: Reviewing the mechanism and current strategies.
    Zhang J; Terreni M; Liu F; Sollogoub M; Zhang Y
    Biomed Pharmacother; 2024 Jul; 176():116824. PubMed ID: 38820973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fully Synthetic Invariant NKT Cell-Dependent Self-Adjuvanting Antitumor Vaccines Eliciting Potent Immune Response in Mice.
    Chen PG; Hu HG; Sun ZY; Li QQ; Zhang BD; Wu JJ; Li WH; Zhao YF; Chen YX; Li YM
    Mol Pharm; 2020 Feb; 17(2):417-425. PubMed ID: 31841011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposome-Based Carbohydrate Vaccine for Simultaneously Eliciting Humoral and Cellular Antitumor Immunity.
    Yao L; Wu L; Wang R; Liu Y; Luo F; Zhang Y; Chen G
    ACS Macro Lett; 2022 Aug; 11(8):975-981. PubMed ID: 35833848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen.
    Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS
    ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.
    Qin Q; Yin Z; Bentley P; Huang X
    Medchemcomm; 2014 Aug; 5(8):1126-1129. PubMed ID: 25396038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbohydrate-based vaccines for oncotherapy.
    Wei MM; Wang YS; Ye XS
    Med Res Rev; 2018 May; 38(3):1003-1026. PubMed ID: 29512174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and immunological evaluation of MUC1 glycopeptide conjugates bearing N-acetyl modified STn derivatives as anticancer vaccines.
    Xiao A; Zheng XJ; Song C; Gui Y; Huo CX; Ye XS
    Org Biomol Chem; 2016 Jul; 14(30):7226-37. PubMed ID: 27380866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recent advance in carbohydrate-based cancer vaccines].
    Huo CX; Ye XS
    Yao Xue Xue Bao; 2012 Mar; 47(3):261-70. PubMed ID: 22645748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbohydrate antigens as targets for active specific immunotherapy.
    Ragupathi G
    Cancer Immunol Immunother; 1996 Nov; 43(3):152-7. PubMed ID: 9001568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-Associated Glycans as Targets for Immunotherapy: The Wistar Institute Experience/Legacy.
    Thurin M
    Monoclon Antib Immunodiagn Immunother; 2021 Jun; 40(3):89-100. PubMed ID: 34161162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids.
    Yin Z; Comellas-Aragones M; Chowdhury S; Bentley P; Kaczanowska K; Benmohamed L; Gildersleeve JC; Finn MG; Huang X
    ACS Chem Biol; 2013; 8(6):1253-62. PubMed ID: 23505965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine.
    Yin Z; Chowdhury S; McKay C; Baniel C; Wright WS; Bentley P; Kaczanowska K; Gildersleeve JC; Finn MG; BenMohamed L; Huang X
    ACS Chem Biol; 2015 Oct; 10(10):2364-72. PubMed ID: 26262839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbohydrate vaccines as immunotherapy for cancer.
    Slovin SF; Keding SJ; Ragupathi G
    Immunol Cell Biol; 2005 Aug; 83(4):418-28. PubMed ID: 16033538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tn antigen analogues: the synthetic way to "upgrade" an attracting tumour associated carbohydrate antigen (TACA).
    Nativi C; Papi F; Roelens S
    Chem Commun (Camb); 2019 Jul; 55(54):7729-7736. PubMed ID: 31225574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of a novel MUC1 glycopeptide conjugate vaccine candidate comprising a 4'-deoxy-4'-fluoro-Thomsen-Friedenreich epitope.
    Johannes M; Reindl M; Gerlitzki B; Schmitt E; Hoffmann-Röder A
    Beilstein J Org Chem; 2015; 11():155-161. PubMed ID: 25670999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation.
    Pecetta S; Lo Surdo P; Tontini M; Proietti D; Zambonelli C; Bottomley MJ; Biagini M; Berti F; Costantino P; Romano MR;
    Vaccine; 2015 Jan; 33(2):314-20. PubMed ID: 25448110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Clickable Monophosphoryl Lipid A Derivatives toward Semisynthetic Conjugates with Tumor-Associated Carbohydrate Antigens.
    Ziaco M; Górska S; Traboni S; Razim A; Casillo A; Iadonisi A; Gamian A; Corsaro MM; Bedini E
    J Med Chem; 2017 Dec; 60(23):9757-9768. PubMed ID: 29045781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.